CAPTRUST FINANCIAL ADVISORS

Position in GH — Guardant Health, Inc.

CIK 1512024 RALEIGH, NC

Position in GH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,863,522

+$1,120,591 QoQ

Shares Held

12,421

+54.4% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#267

of 594 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 48% Shared 0% None 52%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $263,997,654 across 27 Diagnostics & Research names. GH ranks #15 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	90,308	$45,276,818
2	WAT	Waters Corp /De/	87,450	$32,797,248
3	DHR	Danaher Corp /De/	170,806	$32,535,126
4	MTD	Mettler Toledo International Inc/	25,355	$32,391,266
5	MEDP	Medpace Holdings, Inc.	42,922	$22,731,061
6	DGX	Quest Diagnostics Inc	95,054	$20,146,695
7	IDXX	Idexx Laboratories Inc /De	35,025	$18,438,561
8	LH	Labcorp Holdings Inc.	36,472	$10,212,160

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,863,522	12,421	+54.4%	Shares	Sole	2026-08-13
2026-03-31	$742,931	8,043	+256.4%	Shares	Sole	2026-05-15
2025-12-31	$230,529	2,257	+107.6%	Shares	Sole	2026-02-17
2022-06-30	$43,849	1,087	+33.2%	Shares	Sole	2022-08-23
2022-03-31	$54,051	816	-61.6%	Shares	Sole	2022-05-16
2021-12-31	$212,442	2,124	+5.8%	Shares	Sole	2022-02-14
2021-09-30	$250,895	2,007	+9.8%	Shares	Sole	2021-11-16
2021-06-30	$227,019	1,828	-28.1%	Shares	Sole	2021-08-16
2021-03-31	$388,341	2,544	+126.3%	Shares	Sole	2021-05-17
2020-12-31	$144,861	1,124	-8.2%	Shares	Sole	2021-02-16
2020-09-30	$136,818	1,224	0.0%	Shares	Sole	2020-11-17
2020-06-30	$99,303	1,224	-10.9%	Shares	Sole	2020-08-14
2020-03-31	$95,560	1,373	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.